Careers
Jayashree Thakwani's Profile
M.Pharm.Sci
Jayashree holds Masters in Pharmaceutics from Mumbai University. She has extensive experience in R&D of pharmaceutical formulations. Her hobbies include reading, writing, traveling, listening to music and painting.
Written / Edited / Medically Reviewed
US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients
The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.
Machine Learning Models: Improve Heart Disease Diagnosis in Women
A study by scientists shows machine learning models improve prediction of heart disease in women and that sex-specific and patient-specific medicines are future of healthcare.
European Wellness Initiative - Stem Cell Research for Down Syndrome
The collaboration of European Wellness Biomedical Group with EWA, Baden Lab, and Heidelberg University led to a breakthrough research, leading to promising cure for Down Syndrome.
Resmetirom For MASH: Approved by US FDA, Increase in Partnerships
The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.
Semaglutide: A Dominant Player for Patients With Heart Failure
Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.
